PALM BEACH GARDENS, Fla. – March 12, 2019 – Zimmer Biomet today announced that four leading clinicians will present new data that reinforces the value of Trabecular Metal™ Dental Implants to improve outcomes in rapid recovery and risk management cases. The clinicians will also present cases demonstrating the BioBoost Effect™, a multiplication of naturally occurring growth factors that deliver faster healing and earlier bone formation than traditional implants. Zimmer Biomet's Trabecular Metal material is a unique, highly porous biomaterial made from elemental tantalum with a high degree of structural, functional and physiological properties similar to that of human cancellous bone. The presentations will take place during the Corporate Forum track at the Academy of Osseointegration (AO) Annual Meeting on March 14 in Washington, D.C.

“Unlike conventional implants, the Trabecular Metal implant offers three-dimensional bone growth promoting early implant stability, and therefore may offer beneficial conditions for accelerated healing in implant therapy,” said Hai Bo Wen, Clinical Research Director, Zimmer Biomet Dental. “A growing body of clinical evidence suggests that patients with poor bone quality or certain medical conditions that could impair healing can be successfully treated with the Trabecular Metal Dental Implant.”

The following presentations will be given on March 14 in room #146C at the Walter E. Washington Convention Center:

• Rehabilitation of Medically Compromised Patients with Dental Implants - Cristian Peron, DDS

Trabecular Metal™ Technology has been used for more than two decades in orthopedic surgery, especially in patients with osteoporosis, cancer, and co-morbidities. Clinical cases will be presented demonstrating the Trabecular Metal Dental Implant for enhanced secondary stability in poor bone quality in medically compromised patients.

• Revision Therapy: An Answer to an Increasing Epidemic Known as Peri-implantitis - Suheil M. Boutros, DDS, MS

Knowing patients with a previously failed implant are at a higher risk for additional future failures, how can we improve the odds and provide the best standard of care in these situations? This program will introduce Revision Therapy – implant replacement that intensifies the body’s own healing processes to improve predictability in implant replacement. A decision tree for different treatment modalities will be highlighted, including different restorative treatment options such as CAD/CAM abutments to optimize plaque control and maintain       peri-implant health.

• Single Unit to Full-Arch Implant Restoration Using a Rapid Recovery Protocol with Two-Week Loading: A Clinical Perspective - Jason Kennedy, DMD

Proper patient selection and case planning can be a winning combination to improve both productivity and patient satisfaction. This lecture will show attendees how to combine an implant protocol with 5-year clinical follow up with digital scanning and patient-specific restorations for a Rapid Recovery solution completed in a matter of weeks, not months, using Trabecular Metal™ Implants in their practices.

• Predictable Bone Regeneration and Function with Trabecular Metal™ Implants - Monish Bhola, DDS, MSD

This presentation will highlight advances in bone grafting with a focus on the “dual-zone grafting” concept for better aesthetic outcomes. Immediate function and managing failures requires an implant system that fulfills the three “Rs” (Rapid Recovery, Risk Management, and Revision Therapy) of implant therapy, focusing on Trabecular Metal Implants along with regenerative techniques and materials utilized in supporting these advanced treatments.

“We are excited to showcase the latest clinical evidence related to Trabecular Metal, a disruptive technology platform that has the potential to radically improve the field of implant dentistry for a wide range of patients and clinicians,” continued Indraneel Kanaglekar, Vice President, Global Product Management and R&D.  “We are a proud sponsor of the American Academy of Osseointegration Annual Meeting, which complements our deep commitment to excellence in clinical research and professional education.” 

Contact Zimmer Biomet for references to all claims.

About Zimmer Biomet

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.